Invention Grant
- Patent Title: Cholinergic antagonist patch
- Patent Title (中): 胆碱能拮抗剂补片
-
Application No.: US22308Application Date: 1998-02-11
-
Publication No.: US5962012APublication Date: 1999-10-05
- Inventor: Wan-Yan Lin , Shu-Juan Chen , Chao-Wei Liao , Chien-Hsin D. Cheng
- Applicant: Wan-Yan Lin , Shu-Juan Chen , Chao-Wei Liao , Chien-Hsin D. Cheng
- Applicant Address: TWX Hsinchu
- Assignee: Caleb Pharmaceuticals, Inc.
- Current Assignee: Caleb Pharmaceuticals, Inc.
- Current Assignee Address: TWX Hsinchu
- Priority: TWX86117918 19971128
- Main IPC: A61K9/70
- IPC: A61K9/70 ; A61K31/439 ; A61K31/46 ; A61K47/14 ; A61K47/18 ; A61F13/02
Abstract:
Scopolamine is a folksy cholinergic antagonist, and is used by parasympathetic nerves in autonomic nervous neurons as an anti-motion sickness drug or an anti-emesis drug. Since the human body most effectively absorbs this drug through the postauricular skin, the drug is administered by postauricular transdermal resorption patch. The penetrability of drug is increase by adding a dermal penetrative enhancer, because the penetration ability of patch-administered drugs is usually decreased by the penetrative blockade at dermal horny layers. The present invention discloses a penetration enhancer to increase dermal absorption and penetration of the cholinergic antagonist. The present invention finds that polyethylene and amide enhance penetration, about 2.2-2.8 fold. In accordance with the present invention, a penetration enhancer is added to the formulations of transdermal patch to increase the human body's absorption of scopolamine.
Public/Granted literature
- US6047973A In-line skate brakes Public/Granted day:2000-04-11
Information query